These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
232 related articles for article (PubMed ID: 37270717)
1. ITGA3 acts as a purity-independent biomarker of both immunotherapy and chemotherapy resistance in pancreatic cancer: bioinformatics and experimental analysis. Zheng X; Du Y; Liu M; Wang C Funct Integr Genomics; 2023 Jun; 23(2):196. PubMed ID: 37270717 [TBL] [Abstract][Full Text] [Related]
2. ZIP4 Increases Expression of Transcription Factor ZEB1 to Promote Integrin α3β1 Signaling and Inhibit Expression of the Gemcitabine Transporter ENT1 in Pancreatic Cancer Cells. Liu M; Zhang Y; Yang J; Cui X; Zhou Z; Zhan H; Ding K; Tian X; Yang Z; Fung KA; Edil BH; Postier RG; Bronze MS; Fernandez-Zapico ME; Stemmler MP; Brabletz T; Li YP; Houchen CW; Li M Gastroenterology; 2020 Feb; 158(3):679-692.e1. PubMed ID: 31711924 [TBL] [Abstract][Full Text] [Related]
3. ITGA3 and ITGB4 expression biomarkers estimate the risks of locoregional and hematogenous dissemination of oral squamous cell carcinoma. Nagata M; Noman AA; Suzuki K; Kurita H; Ohnishi M; Ohyama T; Kitamura N; Kobayashi T; Uematsu K; Takahashi K; Kodama N; Kawase T; Hoshina H; Ikeda N; Shingaki S; Takagi R BMC Cancer; 2013 Sep; 13():410. PubMed ID: 24006899 [TBL] [Abstract][Full Text] [Related]
4. MicroRNA-124-3p suppresses cell migration and invasion by targeting ITGA3 signaling in bladder cancer. Wang JR; Liu B; Zhou L; Huang YX Cancer Biomark; 2019; 24(2):159-172. PubMed ID: 30614803 [TBL] [Abstract][Full Text] [Related]
5. Identifying the prognosis implication, immunotherapy response prediction value, and potential targeted compound inhibitors of integrin subunit α3 (ITGA3) in human cancers. Gui J; Yang L; Liu J; Li Y; Zou M; Sun C; Huang L; Zhu X; Huang K Heliyon; 2024 Jan; 10(2):e24236. PubMed ID: 38293430 [TBL] [Abstract][Full Text] [Related]
6. Expression and Prognostic Analyses of ITGA3, ITGA5, and ITGA6 in Head and Neck Squamous Cell Carcinoma. Feng C; Jin X; Han Y; Guo R; Zou J; Li Y; Wang Y Med Sci Monit; 2020 Oct; 26():e926800. PubMed ID: 33099569 [TBL] [Abstract][Full Text] [Related]
7. High Expression of ITGA3 Promotes Proliferation and Cell Cycle Progression and Indicates Poor Prognosis in Intrahepatic Cholangiocarcinoma. Huang Y; Kong Y; Zhang L; He T; Zhou X; Yan Y; Zhang L; Zhou D; Lu S; Zhou J; Zhou L; Xie H; Zheng S; Wang W Biomed Res Int; 2018; 2018():2352139. PubMed ID: 29511671 [TBL] [Abstract][Full Text] [Related]
8. Zinc-Dependent Regulation of ZEB1 and YAP1 Coactivation Promotes Epithelial-Mesenchymal Transition Plasticity and Metastasis in Pancreatic Cancer. Liu M; Zhang Y; Yang J; Zhan H; Zhou Z; Jiang Y; Shi X; Fan X; Zhang J; Luo W; Fung KA; Xu C; Bronze MS; Houchen CW; Li M Gastroenterology; 2021 Apr; 160(5):1771-1783.e1. PubMed ID: 33421513 [TBL] [Abstract][Full Text] [Related]
9. A human integrin-α3 mutation confers major renal developmental defects. Shukrun R; Vivante A; Pleniceanu O; Vax E; Anikster Y; Dekel B; Lotan D PLoS One; 2014; 9(3):e90879. PubMed ID: 24621570 [TBL] [Abstract][Full Text] [Related]
10. MicroRNA‑199a‑5p suppresses cell proliferation, migration and invasion by targeting ITGA3 in colorectal cancer. Tian L; Chen M; He Q; Yan Q; Zhai C Mol Med Rep; 2020 Sep; 22(3):2307-2317. PubMed ID: 32705201 [TBL] [Abstract][Full Text] [Related]
11. miRNA-144-5p/ITGA3 Suppressed the Tumor-Promoting Behaviors of Thyroid Cancer Cells by Downregulating ITGA3. Zhang J; Zhong Y; Sang Y; Ren G Comput Math Methods Med; 2021; 2021():9181941. PubMed ID: 34938358 [TBL] [Abstract][Full Text] [Related]
12. Integrin α3 Mediates Stemness and Invasion of Glioblastoma by Regulating POU3F2. Yao J; Wang L Curr Protein Pept Sci; 2023; 24(3):247-256. PubMed ID: 36843258 [TBL] [Abstract][Full Text] [Related]
13. Integrated bioinformatics analysis shows integrin alpha 3 is a prognostic biomarker for pancreatic cancer. Hu F; Zhao L; Wang Y; Ye H; Tang H; Zhou J Open Med (Wars); 2022; 17(1):1935-1943. PubMed ID: 36561844 [TBL] [Abstract][Full Text] [Related]
14. Quantification of m6A RNA methylation modulators pattern was a potential biomarker for prognosis and associated with tumor immune microenvironment of pancreatic adenocarcinoma. Wang L; Zhang S; Li H; Xu Y; Wu Q; Shen J; Li T; Xu Y BMC Cancer; 2021 Jul; 21(1):876. PubMed ID: 34332578 [TBL] [Abstract][Full Text] [Related]
15. Hypoxia-induced changes to integrin α 3 glycosylation facilitate invasion in epidermoid carcinoma cell line A431. Ren Y; Hao P; Law SK; Sze SK Mol Cell Proteomics; 2014 Nov; 13(11):3126-37. PubMed ID: 25078904 [TBL] [Abstract][Full Text] [Related]
16. Genetic and Immunohistochemical Expression of Integrins ITGAV, ITGA6, and ITGA3 As Prognostic Factor for Colorectal Cancer: Models for Global and Disease-Free Survival. Linhares MM; Affonso RJ; Viana Lde S; Silva SR; Denadai MV; de Toledo SR; Matos D PLoS One; 2015; 10(12):e0144333. PubMed ID: 26674523 [TBL] [Abstract][Full Text] [Related]
17. Identification of ITGA3 as an Oncogene in Human Tongue Cancer via Integrated Bioinformatics Analysis. Chen WL; Wang XK; Wu W Curr Med Sci; 2018 Aug; 38(4):714-720. PubMed ID: 30128883 [TBL] [Abstract][Full Text] [Related]
18. Interference with circBC048201 inhibits the proliferation, migration, and invasion of bladder cancer cells through the miR-1184/ITGA3 axis. Jiang P; Zhu Y; Xu Z; Chen X; Xie L Mol Cell Biochem; 2020 Nov; 474(1-2):83-94. PubMed ID: 32789658 [TBL] [Abstract][Full Text] [Related]
19. The expression profile of integrin receptors and osteopontin in thyroid malignancies varies depending on the tumor progression rate and presence of BRAF V600E mutation. Chernaya G; Mikhno N; Khabalova T; Svyatchenko S; Mostovich L; Shevchenko S; Gulyaeva L Surg Oncol; 2018 Dec; 27(4):702-708. PubMed ID: 30449496 [TBL] [Abstract][Full Text] [Related]
20. Decreased Expression of Integrin Subunits α3, α6, and α8 in the Branching Airway Mesenchyme of Nitrofen-Induced Hypoplastic Lungs. Takahashi T; Friedmacher F; Zimmer J; Puri P Eur J Pediatr Surg; 2018 Feb; 28(1):109-114. PubMed ID: 28701000 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]